Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection

Table 1

Comparison of cytokine levels in each group.

Days post infection	Compared to group sham	Group
		Placebo
3 d.p.i.	Significantly higher	IL-1,IL-1, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, IL-13, Eotaxin, G-CSF, GM-CSF, KC, MCP-1(MCAF), MIP-1, MIP-1, RANTES, TNF-	IL-1, IL-1, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, IL-13, Eotaxin, G-CSF, GM-CSF, KC, MCP-1(MCAF), MIP-, RANTES, TNF-
	Significantly lower	/	/
	No significantly different	IL-2, IL-9, IL-17A, IFN-	IL-2, IL-9, IL-17A, IFN-, MIP-1
14 d.p.i.	Significantly higher	/	/
	Significantly lower	IL-3, IL-6, IL-9, IL-12p70, IL-13, Eotaxin, GM-CFS, IFN-, MCP-1(MCAF), RANTES, TNF-	/
	No significantly different	IL-1, IL-1, IL-2, IL-4, IL-5, IL-10, IL-12p40, IL =17A, G-CSF, KC, MIP-1, MIP-1	IL-1, IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12p40, IL-12p70, IL-13, IL =17A, Eotaxin, G-CSF, GM-CSF, IFN-, KC, MCP-1(MCAF), MIP-1, MIP-1, RANTES, TNF-